These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

159 related items for PubMed ID: 15744816

  • 1. Cyclooxygenase-2 and p53 expression as prognostic indicators in conventional renal cell carcinoma.
    Cho DS, Joo HJ, Oh DK, Kang JH, Kim YS, Lee KB, Kim SJ.
    Yonsei Med J; 2005 Feb 28; 46(1):133-40. PubMed ID: 15744816
    [Abstract] [Full Text] [Related]

  • 2. The expression of thrombospondin-1 and p53 in clear cell renal cell carcinoma: its relationship to angiogenesis, cell proliferation and cancer specific survival.
    Zubac DP, Bostad L, Kihl B, Seidal T, Wentzel-Larsen T, Haukaas SA.
    J Urol; 2009 Nov 28; 182(5):2144-9. PubMed ID: 19758660
    [Abstract] [Full Text] [Related]

  • 3. Value of p53 as a prognostic marker in histologic subtypes of renal cell carcinoma: a systematic analysis of primary and metastatic tumor tissue.
    Zigeuner R, Ratschek M, Rehak P, Schips L, Langner C.
    Urology; 2004 Apr 28; 63(4):651-5. PubMed ID: 15072872
    [Abstract] [Full Text] [Related]

  • 4. Expression of cyclooxygenase-2 in renal cell carcinoma: correlation with tumor cell proliferation, apoptosis, angiogenesis, expression of matrix metalloproteinase-2, and survival.
    Miyata Y, Koga S, Kanda S, Nishikido M, Hayashi T, Kanetake H.
    Clin Cancer Res; 2003 May 28; 9(5):1741-9. PubMed ID: 12738729
    [Abstract] [Full Text] [Related]

  • 5. Increased expression of Chitinase 3-like 1 and microvessel density predicts metastasis and poor prognosis in clear cell renal cell carcinoma.
    Zhang JP, Yuan HX, Kong WT, Liu Y, Lin ZM, Wangs WP, Guo JM.
    Tumour Biol; 2014 Dec 28; 35(12):12131-7. PubMed ID: 25142236
    [Abstract] [Full Text] [Related]

  • 6. The prognostic value of peritumoral regulatory T cells and its correlation with intratumoral cyclooxygenase-2 expression in clear cell renal cell carcinoma.
    Li JF, Chu YW, Wang GM, Zhu TY, Rong RM, Hou J, Xu M.
    BJU Int; 2009 Feb 28; 103(3):399-405. PubMed ID: 19021626
    [Abstract] [Full Text] [Related]

  • 7. P53 and MDM2 Over-expression and Five-year Survival of Kidney Cancer Patients Undergoing Radical Nephrectomy--Iranian Experience.
    Abolhasani M, Salarinejad S, Asgari M.
    Asian Pac J Cancer Prev; 2015 Feb 28; 16(12):5043-7. PubMed ID: 26163638
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. BUB1B Overexpression Is an Independent Prognostic Marker and Associated with CD44, p53, and PD-L1 in Renal Cell Carcinoma.
    Sekino Y, Han X, Kobayashi G, Babasaki T, Miyamoto S, Kobatake K, Kitano H, Ikeda K, Goto K, Inoue S, Hayashi T, Teishima J, Sakamoto N, Sentani K, Oue N, Yasui W, Matsubara A.
    Oncology; 2021 Feb 28; 99(4):240-250. PubMed ID: 33588420
    [Abstract] [Full Text] [Related]

  • 10. Prognostic evaluation of COX-2 expression in renal cell carcinoma.
    Kankuri-Tammilehto MK, Söderström KO, Pelliniemi TT, Vahlberg T, Pyrhönen SO, Salminen EK.
    Anticancer Res; 2010 Jul 28; 30(7):3023-30. PubMed ID: 20683050
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Overexpression of cyclooxygenase-1 correlates with poor prognosis in renal cell carcinoma.
    Yu ZH, Zhang Q, Wang YD, Chen J, Jiang ZM, Shi M, Guo X, Qin J, Cui GH, Cai ZM, Gui YT, Lai YQ.
    Asian Pac J Cancer Prev; 2013 Jul 28; 14(6):3729-34. PubMed ID: 23886173
    [Abstract] [Full Text] [Related]

  • 13. Hypoxia-inducible factor 1 alpha in clear cell renal cell carcinoma.
    Klatte T, Seligson DB, Riggs SB, Leppert JT, Berkman MK, Kleid MD, Yu H, Kabbinavar FF, Pantuck AJ, Belldegrun AS.
    Clin Cancer Res; 2007 Dec 15; 13(24):7388-93. PubMed ID: 18094421
    [Abstract] [Full Text] [Related]

  • 14. Cyclooxygenase-2 and p53 expressions in endometrial cancer.
    Jeon YT, Kang S, Kang DH, Yoo KY, Park IA, Bang YJ, Kim JW, Park NH, Kang SB, Lee HP, Song YS.
    Cancer Epidemiol Biomarkers Prev; 2004 Sep 15; 13(9):1538-42. PubMed ID: 15342458
    [Abstract] [Full Text] [Related]

  • 15. Expression of cyclooxygenase-2 and EP4 receptor in transitional cell carcinoma of the upper urinary tract.
    Miyata Y, Kanda S, Nomata K, Eguchi J, Kanetake H.
    J Urol; 2005 Jan 15; 173(1):56-60. PubMed ID: 15592025
    [Abstract] [Full Text] [Related]

  • 16. Prognostic and diagnostic implications of epithelial cell adhesion/activating molecule (EpCAM) expression in renal tumours: a retrospective clinicopathological study of 948 cases using tissue microarrays.
    Zimpfer A, Maruschke M, Rehn S, Kundt G, Litzenberger A, Dammert F, Zettl H, Stephan C, Hakenberg OW, Erbersdobler A.
    BJU Int; 2014 Aug 15; 114(2):296-302. PubMed ID: 24215118
    [Abstract] [Full Text] [Related]

  • 17. pT1 clear cell renal cell carcinoma: a study of the association between MIB-1 proliferative activity and pathologic features and cancer specific survival.
    Cheville JC, Zincke H, Lohse CM, Sebo TJ, Riehle D, Weaver AL, Blute ML.
    Cancer; 2002 Apr 15; 94(8):2180-4. PubMed ID: 12001115
    [Abstract] [Full Text] [Related]

  • 18. Increased expression of caveolin-1 and microvessel density correlates with metastasis and poor prognosis in clear cell renal cell carcinoma.
    Joo HJ, Oh DK, Kim YS, Lee KB, Kim SJ.
    BJU Int; 2004 Feb 15; 93(3):291-6. PubMed ID: 14764125
    [Abstract] [Full Text] [Related]

  • 19. Expression of bcl-2, p53 oncoprotein, and proliferating cell nuclear antigen in renal cell carcinoma.
    Sejima T, Miyagawa I.
    Eur Urol; 1999 Feb 15; 35(3):242-8. PubMed ID: 10072628
    [Abstract] [Full Text] [Related]

  • 20. Prognostic significance of ploidy, MIB-1 proliferation marker, and p53 in renal cell carcinoma.
    Kramer BA, Gao X, Davis M, Hall M, Holzbeierlein J, Tawfik O.
    J Am Coll Surg; 2005 Oct 15; 201(4):565-70. PubMed ID: 16183495
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.